Rituximab-associated hypogammaglobulinemia: incidence, predictors and outcomes in patients with multi-system autoimmune disease.

MLA

Roberts, Darren M., et al. “Rituximab-Associated Hypogammaglobulinemia: Incidence, Predictors and Outcomes in Patients with Multi-System Autoimmune Disease.” Journal of Autoimmunity, vol. 57, Feb. 2015, pp. 60–65. EBSCOhost, https://doi.org/10.1016/j.jaut.2014.11.009.

APA

Roberts, D. M., Jones, R. B., Smith, R. M., Alberici, F., Kumaratne, D. S., Burns, S., & Jayne, D. R. W. (2015). Rituximab-associated hypogammaglobulinemia: incidence, predictors and outcomes in patients with multi-system autoimmune disease. Journal of Autoimmunity, 57, 60–65. https://doi.org/10.1016/j.jaut.2014.11.009

Chicago

Roberts, Darren M, Rachel B Jones, Rona M Smith, Federico Alberici, Dinakantha S Kumaratne, Stella Burns, and David R W Jayne. 2015. “Rituximab-Associated Hypogammaglobulinemia: Incidence, Predictors and Outcomes in Patients with Multi-System Autoimmune Disease.” Journal of Autoimmunity 57 (February): 60–65. doi:10.1016/j.jaut.2014.11.009.